Molecular determinants of invasion in endometrial cancer
- PMID: 17525037
- DOI: 10.1007/s12094-007-0054-z
Molecular determinants of invasion in endometrial cancer
Abstract
Endometrial carcinoma is the most common gynaecological malignancy in the western world and the most frequent among infiltrating tumours of the female genital tract. Despite the characterisation of molecular events associated with the development of endometrial carcinoma, those associated with the early steps of infiltration and invasion in endometrial cancer are less known. Deep myometrial invasion correlates with more undifferentiated tumours, lymph-vascular invasion, node affectation and decreased global survival. In this review we present an overview of the molecular pathology of myometrial infiltration that defines the initial steps of invasion in endometrial cancer. Down-regulation of E-cadherin as a main player of epithelial to mesenchymal transition, as well as modifications on other molecules involved in cell-cell contacts, render cells with a migratory phenotype. In addition, altered signalling pathways and transcription factors associate with myometrial invasion, histologic grade and metastasis.
Similar articles
-
Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress.Carcinogenesis. 2009 Aug;30(8):1288-97. doi: 10.1093/carcin/bgp119. Epub 2009 May 14. Carcinogenesis. 2009. PMID: 19443906
-
[Abnormal E-cadherin expression as a risk factor for deep myometrial invasion and lymph node metastasis in endometrial carcinoma].Nihon Rinsho. 1995 Jul;53(7):1607-12. Nihon Rinsho. 1995. PMID: 7629996 Japanese.
-
Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion.Gynecol Oncol. 1994 May;53(2):183-9. doi: 10.1006/gyno.1994.1113. Gynecol Oncol. 1994. PMID: 8188077
-
Peritumorous lymph-vascular invasion, grade of histologic differentiation, and myometrial infiltration as prognostic factors of endometrial carcinoma.Rev Paul Med. 1993 May-Jun;111(3):385-90. Rev Paul Med. 1993. PMID: 8108630 Review.
-
The EMT signaling pathways in endometrial carcinoma.Clin Transl Oncol. 2012 Oct;14(10):715-20. doi: 10.1007/s12094-012-0866-3. Epub 2012 Aug 22. Clin Transl Oncol. 2012. PMID: 22911547 Review.
Cited by
-
Endometrial Tumour Microenvironment.Adv Exp Med Biol. 2020;1296:215-225. doi: 10.1007/978-3-030-59038-3_13. Adv Exp Med Biol. 2020. PMID: 34185295
-
Pilot Study to Establish a Novel Five-Gene Biomarker Panel for Predicting Lymph Node Metastasis in Patients With Early Stage Endometrial Cancer.Front Oncol. 2020 Jan 21;9:1508. doi: 10.3389/fonc.2019.01508. eCollection 2019. Front Oncol. 2020. PMID: 32039004 Free PMC article.
-
Molecular determinants for lymph node metastasis in clinically early-stage endometrial cancer.Oncol Lett. 2016 Jan;11(1):323-329. doi: 10.3892/ol.2015.3883. Epub 2015 Nov 6. Oncol Lett. 2016. PMID: 26870211 Free PMC article.
-
An early-screening biomarker of endometrial carcinoma: NGAL is associated with epithelio-mesenchymal transition.Oncotarget. 2016 Dec 27;7(52):86064-86074. doi: 10.18632/oncotarget.13340. Oncotarget. 2016. PMID: 27863382 Free PMC article.
-
Over-Expression of the LH Receptor Increases Distant Metastases in an Endometrial Cancer Mouse Model.Front Oncol. 2013 Nov 19;3:285. doi: 10.3389/fonc.2013.00285. eCollection 2013. Front Oncol. 2013. PMID: 24312898 Free PMC article.